Search

everythinglearnresearchcommunity

for

Search:↓

New alopecia treatments aim for better results and fewer side effects.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Type I interferons play a key role in the development of various skin diseases.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

N-WASP is essential for healthy skin and preventing inflammation.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.